XBI — every tracked call

XBI

10 tracked calls · 9 long · 1 short · last 90d: 8L/1S

first called by TBPN 3mo ago

XBIXBISHORT3d ago

“I'm bearish on like the application of biotech and AI. And the reason is just national security... the second you have one event, just one event, it'll be banned”

1000x

Regulators will crush the biotech sector with outright bans because the national security risk of 1 guy in a garage generating an AI pathogen is too high.

XBIXBISHORT@ $150.82

$146.85+2.63%

since call Jul 28

peak +2.6%

Trade on Robinhood →

XBIXBILONG1w agoFLIPPED

“biotech for example in this entire massive draw down in the markets uh kind of didn't really move that much... taking them down and I'm shoving them into uh you know the the next stage the next stage ”

1000x

Biotech completely ignored the recent 30% memory stock drawdown, making it the perfect downstream vault to absorb profits from the next AI hardware rally.

XBIXBILONG@ $152.23

EXIT$149.78-1.61%

since call Jul 22

peak +0.8%

flipped Jul 28 · held 6d · record frozen at -1.61%

Trade on Robinhood →

XBIXBILONG3w ago

“healthcare has made some very notable uh progress. We have a allocation to biotech which has been super strong almost a little too strong too quick.”

Thoughtful Money · Adam Taggart | Thoughtful Money®

Investors are rotating capital out of frothy tech monopolies and piling into beaten-down biotech names, pushing the sector up 23.9% in the second quarter.

XBIXBILONG@ $162.37

$146.85-9.56%

since call Jul 5

Trade on Robinhood →

XBIXBILONG4w ago

“The rotation from tech to healthcare signals a shift in market sentiment towards defensive sectors amid tech volatility boosting bioarmmer valuations. Now here's the chart we just consolidated for thi”

Jordi Visser

Capital is rotating out of the Mag 7 and fueling an 8% surge in healthcare as the biotech renaissance takes off.

XBIXBILONG@ $154.17

$146.85-4.75%

since call Jun 28

peak +2.3%

Trade on Robinhood →

XBIXBILONG4w ago

“A return could signal an attempt to stabilize the regulator rocked by months of turmoil”

Matthew Herper

Pazdur's return to FDA signals regulatory stabilization, lifting biotech stocks beaten down by months of FDA turmoil.

XBIXBILONG@ $154.46

$146.85-4.93%

since call Jun 28

peak +0.6%

Trade on Robinhood →

XBIXBILONG1mo agoFLIPPED

“Another example is why I'm spending all this time on biotech and why I just bought a ton more ARKG and I bought a lot more of the XBI biotech uh ETF.”

1000x

The AI trade is moving past the $700 billion hyperscaler buildout, so buy the XBI biotech ETF to catch the next wave of downstream real-world applications.

XBIXBILONG@ $151.59

EXIT$149.78-1.19%

since call Jun 24

peak +4.9%

flipped Jul 28 · held 34d · record frozen at -1.19%

Trade on Robinhood →

XBIXBILONG1mo ago

“biotech, as of today, we see XBI breaking out to the highest level in about 5 years. Healthcare clearly in a very seasonally bullish time.”

Thoughtful Money · Mark Newton

Biotech breaking out to 5-year highs into a seasonally bullish healthcare window

XBIXBILONG@ $139.70

$146.85+5.12%